Home › Funds › Pale Fire Capital SE › HRTX
Pale Fire Capital SE position in HRTX
HERON THERAPEUTICS INC · Health Care
Pale Fire Capital SE reported holding 2,511,478 shares of HRTX (HERON THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.1M, representing 0.08% of its reported portfolio and ranking #35 among its reported holdings. Pale Fire Capital SE has disclosed HRTX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Pale Fire Capital SE's HRTX position evolved
Pale Fire Capital SE first disclosed a stake in HRTX in Q3 2025 at 471,190 shares (US$594K). The position peaked in Q1 2026 at 2,716,328 shares, worth US$2.2M. Across 4 filings, Pale Fire Capital SE increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,511,478 shares valued at US$1.1M — a reduction of -204,850 shares quarter over quarter.. Notable position changes include a 212% increase in Q4 2025 (shares fell 38% over the following quarter), a 85% increase in Q1 2026 (shares fell 46% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 471.19K | $593.70K | New |
| Q4 2025 | 1.47M | $1.91M | Add |
| Q1 2026 | 2.72M | $2.17M | Add |
| Q2 2026 | 2.51M | $1.07M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HRTX and 13F data
HRTX (HERON THERAPEUTICS INC) is a Health Care company. 9 other funds we track also report a position in HRTX — the largest reported positions include Velan Capital Investment Management LP (US$3.7M), Tejara Capital Ltd (US$2.8M), TANG CAPITAL MANAGEMENT LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HRTX
- Velan Capital Investment Management LP 8.75M sh · $3.74M · Q2 2026
- Tejara Capital Ltd 6.51M sh · $2.78M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 6.25M sh · $2.67M · Q2 2026
More on Pale Fire Capital SE
FAQ
How long has Pale Fire Capital SE held HRTX?
Pale Fire Capital SE has disclosed HRTX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Pale Fire Capital SE's current position in HRTX?
As of Q2 2026, Pale Fire Capital SE holds 2.51M shares of HRTX (HERON THERAPEUTICS INC), valued at $1.07M, representing 0.08% of its reported portfolio and ranking #35.
Has Pale Fire Capital SE been buying or selling HRTX?
In the latest 13F filing (Q2 2026), Pale Fire Capital SE reduced its position in HRTX. The position peaked in Q1 2026 at 2.72M shares.
Which other funds hold HRTX?
Other major institutional holders of HRTX include Velan Capital Investment Management LP, Tejara Capital Ltd, TANG CAPITAL MANAGEMENT LLC, among 9 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.